🔎 Trials Near Me

홈 › 전립선암 › 콜로라도

콜로라도의 전립선암 임상 시험

전립선암 관련 연구 40개가 콜로라도 내 여러 지역에서 참여자를 모집하고 있습니다.

콜로라도의 도시

공식 연구 텍스트(영어)

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  • Penrose-Saint Francis Healthcare, Colorado Springs
  • Rocky Mountain Cancer Centers-Penrose, Colorado Springs
  • Saint Francis Cancer Center, Colorado Springs
  • 외 6개
피험자 모집 중3상
18세 이상 · 남성 · 2026. 11. 13. 업데이트됨 · NCT04423211

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

  • Rocky Mountain Cancer Centers, Denver
피험자 모집 중1상
18세 이상 · 남성 · 2026. 11. 12. 업데이트됨 · NCT04221542

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Keefe Memorial Hospital, Cheyenne Wells
  • Kaiser Permanente-Franklin, Denver
  • Poudre Valley Hospital, Fort Collins
  • 외 5개
피험자 모집 중건강한 지원자 환영
45세 ~ 75세 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT06995898

WATER IV PCa (AS Sub-study)

  • Boulder Medical Center, Boulder
피험자 모집 중
45세 이상 · 남성 · 2026. 11. 6. 업데이트됨 · NCT07650448

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

  • Rocky Mountain Cancer Center, Colorado Springs
피험자 모집 중2상
18세 이상 · 남성 · 2026. 11. 5. 업데이트됨 · NCT07745361

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • Sarah Cannon Research Institute at HealthOne, Denver
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06465069

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Rocky Mountain Regional VA Medical Center, Aurora
  • UCHealth University of Colorado Hospital, Aurora
  • Penrose-Saint Francis Healthcare, Colorado Springs
  • 외 15개
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

  • UCHealth Memorial Hospital Central, Colorado Springs
  • Memorial Hospital North, Colorado Springs
  • Poudre Valley Hospital, Fort Collins
  • 외 3개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT06632977

A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

  • University of Colorado Anschutz Medical Campus, Aurora
피험자 모집 중1상
18세 이상 · 남성 · 2026. 11. 3. 업데이트됨 · NCT06095089

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

  • UCHealth University of Colorado Hospital, Aurora
  • UCHealth Memorial Hospital Central, Colorado Springs
  • Memorial Hospital North, Colorado Springs
피험자 모집 중3상
18세 이상 · 남성 · 2026. 11. 3. 업데이트됨 · NCT07200830

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  • Rocky Mountain Regional VA Medical Center, Aurora
  • Kaiser Permanente-Franklin, Denver
  • Shaw Cancer Center, Edwards
  • 외 3개
피험자 모집 중3상
18세 이상 · 남성 · 2026. 11. 3. 업데이트됨 · NCT06931340

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

  • Rocky Mountain Cancer Center, Colorado Springs
  • Sarah Cannon Research Institute 1, Denver
피험자 모집 중1/2상
18세 이상 · 남성 · 2026. 11. 3. 업데이트됨 · NCT06800313

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  • Rocky Mountain Regional Veterans Affairs Medical Center ( Site 0053), Aurora
피험자 모집 중3상
18세 이상 · 남성 · 2026. 10. 30. 업데이트됨 · NCT06925737

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • UCHealth University of Colorado Hospital, Aurora
  • Rocky Mountain Cancer Centers-Penrose, Colorado Springs
  • UCHealth Memorial Hospital Central, Colorado Springs
  • 외 2개
피험자 모집 중3상
18세 이상 · 남성 · 2026. 10. 23. 업데이트됨 · NCT05946213

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  • University of Colorado Anschutz Medical Campus ( Site 0046), Aurora
  • UCHealth Highlands Ranch Hospital ( Site 0111), Highlands Ranch
  • Colorado Clinical Research ( Site 0067), Lakewood
  • 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 20. 업데이트됨 · NCT06136650

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

  • Sarah Cannon Research Institute - Denver DDU, Denver
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 20. 업데이트됨 · NCT06582017

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

  • Rocky Mountain Cancer Centers, Denver
피험자 모집 중3상
18세 이상 · 남성 · 2026. 10. 20. 업데이트됨 · NCT07213674

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

  • Research Site, Aurora
피험자 모집 중3상
18세 이상 · 남성 · 2026. 10. 19. 업데이트됨 · NCT07611110

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

  • Sarah Cannon Research Institute, Denver
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 15. 업데이트됨 · NCT06239194

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

  • Rocky Mountain Cancer Centers, Denver
피험자 모집 중3상
18세 ~ 100세 · 남성 · 2026. 10. 15. 업데이트됨 · NCT06855277

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

  • Research Site, Lakewood
피험자 모집 중3상
18세 이상 · 남성 · 2026. 10. 14. 업데이트됨 · NCT06952803

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

  • AdventHealth Medical Group Urology of Denver, Denver
피험자 모집 중3상
18세 이상 · 남성 · 2026. 10. 14. 업데이트됨 · NCT07028853

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  • University of Colorado Hospital, Aurora
  • Rocky Mountain Cancer Centers-Boulder, Boulder
  • UCHealth Memorial Hospital Central, Colorado Springs
  • 외 8개
피험자 모집 중3상
18세 이상 · 남성 · 2026. 10. 8. 업데이트됨 · NCT03678025

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • University of Colorado, Aurora
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 7. 업데이트됨 · NCT05919264

A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer

  • GSK Investigational Site, Denver
피험자 모집 중1/2상
18세 이상 · 남성 · 2026. 10. 5. 업데이트됨 · NCT06990880

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Rocky Mountain Cancer Center, Denver
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT04585750

DESTINY-PANTUMOUR04

  • Research Site, Boulder
피험자 모집 중관찰 연구
18세 ~ 130세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07124000

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

  • Rocky Mountain Cancer Centers, Denver
피험자 모집 중2/3상
18세 ~ 100세 · 남성 · 2026. 9. 22. 업데이트됨 · NCT06780670

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

  • Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora
피험자 모집 중2상
18세 이상 · 남성 · 2026. 9. 17. 업데이트됨 · NCT05011383

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

  • Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora
피험자 모집 중2상
18세 이상 · 남성 · 2026. 9. 17. 업데이트됨 · NCT04038502

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

  • Colorado Clinical Research, Lakewood
  • Urology Associates, Littleton
피험자 모집 중2상
18세 이상 · 남성 · 2026. 9. 15. 업데이트됨 · NCT07332000

Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

  • Rocky Mountain Cancer Centers, Denver
  • United States Oncology Regulatory Affairs Corporate Office, Denver
  • US Oncology Research Investigational Products Center, Denver
피험자 모집 중1상
18세 이상 · 남성 · 2026. 9. 15. 업데이트됨 · NCT07493512

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

  • University of Colorado Health, Aurora
피험자 모집 중1/2상
18세 이상 · 남성 · 2026. 8. 20. 업데이트됨 · NCT06785636

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  • UCHealth University of Colorado Hospital, Aurora
  • Penrose-Saint Francis Healthcare, Colorado Springs
  • Rocky Mountain Cancer Centers-Penrose, Colorado Springs
  • 외 18개
피험자 모집 중3상
18세 이상 · 남성 · 2026. 7. 14. 업데이트됨 · NCT06592924

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

  • Rocky Mountain Cancer Center, Colorado Springs
피험자 모집 중1상
18세 이상 · 남성 · 2026. 7. 9. 업데이트됨 · NCT05413421

Integrated Cancer Repository for Cancer Research

  • Advent Health, Greenwood Village
피험자 모집 중관찰 연구건강한 지원자 환영
19세 ~ 110세 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT02012699

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

  • University of Colorado, Aurora
피험자 모집 중4상
18세 ~ 100세 · 남성 · 2026. 6. 4. 업데이트됨 · NCT05803941

Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors

  • University of Colorado Anschutz Medical Campus, Aurora
피험자 모집 중2상
18세 ~ 89세 · 모든 성별 · 2026. 2. 5. 업데이트됨 · NCT07001241

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

  • Penrose-Saint Francis Healthcare, Colorado Springs
  • Rocky Mountain Cancer Centers-Penrose, Colorado Springs
  • Saint Francis Cancer Center, Colorado Springs
  • 외 8개
피험자 모집 중2상
18세 이상 · 남성 · 2026. 1. 29. 업데이트됨 · NCT05806515

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Aurora
  • Massive Bio SYNERGY-AI site, Denver
  • Massive Bio SYNERGY-AI site, Littleton
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.